Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 473

1.

The MINDVIEW project: First results.

Benlloch JM, González AJ, Pani R, Preziosi E, Jackson C, Murphy J, Barberá J, Correcher C, Aussenhofer S, Gareis D, Visvikis D, Bert J, Langstrom B, Farde L, Toth M, Haggkvist J, Caixeta FV, Kullander K, Somlai-Schweiger I, Schwaiger M.

Eur Psychiatry. 2018 Apr;50:21-27. doi: 10.1016/j.eurpsy.2018.01.002. Epub 2018 Feb 2.

PMID:
29398564
2.

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening.

Kumar R, Kumar A, Långström B, Darreh-Shori T.

Sci Rep. 2017 Nov 24;7(1):16287. doi: 10.1038/s41598-017-16033-w.

3.

Effect of Alzheimer Familial Chromosomal Mutations on the Amyloid Fibril Interaction with Different PET Tracers: Insight from Molecular Modeling Studies.

Balamurugan K, Murugan NA, Långström B, Nordberg A, Ågren H.

ACS Chem Neurosci. 2017 Dec 20;8(12):2655-2666. doi: 10.1021/acschemneuro.7b00215. Epub 2017 Oct 3.

PMID:
28898051
4.

Development of [11C]/[3H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligand.

Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, Furumoto S, Mitsios N, Mulder J, Långström B, Nordberg A, Halldin C.

Nucl Med Biol. 2017 Mar;46:50-53. doi: 10.1016/j.nucmedbio.2016.12.004. Epub 2016 Dec 9.

PMID:
28013122
5.

Theoretical study of the binding profile of an allosteric modulator NS-1738 with a chimera structure of the α7 nicotinic acetylcholine receptor.

Kuang G, Wang X, Halldin C, Nordberg A, Långström B, Ågren H, Tu Y.

Phys Chem Chem Phys. 2016 Oct 12;18(40):28003-28009.

PMID:
27711412
6.

Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.

Ni R, Gillberg PG, Bogdanovic N, Viitanen M, Myllykangas L, Nennesmo I, Långström B, Nordberg A.

Alzheimers Dement. 2017 Apr;13(4):419-430. doi: 10.1016/j.jalz.2016.08.006. Epub 2016 Sep 28.

PMID:
27693181
7.

Decreased Brain Neurokinin-1 Receptor Availability in Chronic Tennis Elbow.

Linnman C, Catana C, Svärdsudd K, Appel L, Engler H, Långström B, Sörensen J, Furmark T, Fredrikson M, Borsook D, Peterson M.

PLoS One. 2016 Sep 22;11(9):e0161563. doi: 10.1371/journal.pone.0161563. eCollection 2016.

8.

Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.

Frick A, Åhs F, Appel L, Jonasson M, Wahlstedt K, Bani M, Merlo Pich E, Bettica P, Långström B, Lubberink M, Fredrikson M, Furmark T.

Eur Neuropsychopharmacol. 2016 Nov;26(11):1775-1783. doi: 10.1016/j.euroneuro.2016.09.004. Epub 2016 Sep 15.

PMID:
27642077
9.

Women with Premenstrual Dysphoria Lack the Seemingly Normal Premenstrual Right-Sided Relative Dominance of 5-HTP-Derived Serotonergic Activity in the Dorsolateral Prefrontal Cortices - A Possible Cause of Disabling Mood Symptoms.

Eriksson O, Wall A, Olsson U, Marteinsdottir I, Holstad M, Ågren H, Hartvig P, Långström B, Naessén T.

PLoS One. 2016 Sep 12;11(9):e0159538. doi: 10.1371/journal.pone.0159538. eCollection 2016.

10.

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization.

Kumar R, Långström B, Darreh-Shori T.

Sci Rep. 2016 Aug 10;6:31247. doi: 10.1038/srep31247.

11.

The Culprit Is in the Cave: The Core Sites Explain the Binding Profiles of Amyloid-Specific Tracers.

Murugan NA, Halldin C, Nordberg A, Långström B, Ågren H.

J Phys Chem Lett. 2016 Sep 1;7(17):3313-21. doi: 10.1021/acs.jpclett.6b01586. Epub 2016 Aug 12.

PMID:
27498616
12.

Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder.

Furmark T, Marteinsdottir I, Frick A, Heurling K, Tillfors M, Appel L, Antoni G, Hartvig P, Fischer H, Långström B, Eriksson E, Fredrikson M.

J Psychopharmacol. 2016 Oct;30(10):1028-35. doi: 10.1177/0269881116648317. Epub 2016 May 17.

PMID:
27189957
13.

Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.

Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A.

J Nucl Med. 2016 Jul;57(7):1071-7. doi: 10.2967/jnumed.115.168732. Epub 2016 Feb 16.

14.

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.

Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A.

Brain. 2016 Mar;139(Pt 3):922-36. doi: 10.1093/brain/awv404. Epub 2016 Jan 26.

15.

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.

Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A.

Sci Rep. 2015 Nov 10;5:16404. doi: 10.1038/srep16404.

16.

Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.

Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H.

J Alzheimers Dis. 2015;47(3):691-704. doi: 10.3233/JAD-132474.

PMID:
26401704
17.

Synthesis of ([(11)C]carbonyl)raclopride and a comparison with ([(11)C]methyl)raclopride in a monkey PET study.

Rahman O, Takano A, Amini N, Dahl K, Kanegawa N, Långström B, Farde L, Halldin C.

Nucl Med Biol. 2015 Nov;42(11):893-8. doi: 10.1016/j.nucmedbio.2015.07.003. Epub 2015 Jul 15.

PMID:
26272268
18.

Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171.

Frick A, Ahs F, Linnman C, Jonasson M, Appel L, Lubberink M, Långström B, Fredrikson M, Furmark T.

Transl Psychiatry. 2015 Jul 7;5:e597. doi: 10.1038/tp.2015.92.

19.

Endogenous compounds labeled with radionuclides of short half-life-some perspectives.

Långström B, Karimi F, Watanabe Y.

J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):251-62. doi: 10.1002/jlcr.3033. Review.

PMID:
24285332
20.

Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET.

Appel L, Bergström M, Buus Lassen J, Långström B.

Eur Neuropsychopharmacol. 2014 Feb;24(2):251-61. doi: 10.1016/j.euroneuro.2013.10.007. Epub 2013 Oct 22.

PMID:
24239329
21.

PET-scan shows peripherally increased neurokinin 1 receptor availability in chronic tennis elbow: visualizing neurogenic inflammation?

Peterson M, Svärdsudd K, Appel L, Engler H, Aarnio M, Gordh T, Långström B, Sörensen J.

PLoS One. 2013 Oct 14;8(10):e75859. doi: 10.1371/journal.pone.0075859. eCollection 2013.

22.

Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.

Darreh-Shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom RP, Nilsson B, Ekdahl KN, Långström B, Almkvist O, Nordberg A.

Neurobiol Aging. 2013 Nov;34(11):2465-81. doi: 10.1016/j.neurobiolaging.2013.04.027. Epub 2013 Jun 4.

PMID:
23759148
23.

Amyloid-β positron emission tomography imaging probes: a critical review.

Kepe V, Moghbel MC, Långström B, Zaidi H, Vinters HV, Huang SC, Satyamurthy N, Doudet D, Mishani E, Cohen RM, Høilund-Carlsen PF, Alavi A, Barrio JR.

J Alzheimers Dis. 2013;36(4):613-31. doi: 10.3233/JAD-130485. Review.

24.

Improving the diagnosis and management of neuroendocrine tumors: utilizing new advances in biomarker and molecular imaging science.

Giandomenico V, Modlin IM, Pontén F, Nilsson M, Landegren U, Bergqvist J, Khan MS, Millar RP, Långström B, Borlak J, Eriksson B, Nielsen B, Baltzer L, Waterton JC, Ahlström H, Öberg K.

Neuroendocrinology. 2013;98(1):16-30. doi: 10.1159/000348832. Epub 2013 Jun 28.

25.

Molecular imaging in breast cancer.

Ruibal A, Benlloch JM, Olmos RV, Langstrom B.

J Oncol. 2012;2012:426260. doi: 10.1155/2012/426260. Epub 2012 Dec 29. No abstract available.

26.

In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.

Antoni G, Lubberink M, Estrada S, Axelsson J, Carlson K, Lindsjö L, Kero T, Långström B, Granstam SO, Rosengren S, Vedin O, Wassberg C, Wikström G, Westermark P, Sörensen J.

J Nucl Med. 2013 Feb;54(2):213-20. doi: 10.2967/jnumed.111.102053. Epub 2012 Dec 13.

27.

In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargeting.

Hall H, Velikyan I, Blom E, Ulin J, Monazzam A, Påhlman L, Micke P, Wanders A, McBride W, Goldenberg DM, Långström B.

Am J Nucl Med Mol Imaging. 2012;2(2):141-50. Epub 2012 Mar 28.

28.

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.

Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, Långström B, Scheinin N, Karrasch M, Någren K, Grimmer T, Miederer I, Edison P, Okello A, Van Laere K, Nelissen N, Vandenbulcke M, Garibotto V, Almkvist O, Kalbe E, Hinz R, Herholz K.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):104-14. doi: 10.1007/s00259-012-2237-2. Epub 2012 Sep 8.

29.

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.

Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, Långström B, Almkvist O, Graff C, Nordberg A.

Neurology. 2012 Jul 17;79(3):229-36. doi: 10.1212/WNL.0b013e31825fdf18. Epub 2012 Jun 13.

PMID:
22700814
30.

Imaging astrocytosis with PET in Creutzfeldt-Jakob disease: case report with histopathological findings.

Engler H, Nennesmo I, Kumlien E, Gambini JP, Lundberg P, Savitcheva I, Långström B.

Int J Clin Exp Med. 2012;5(2):201-7. Epub 2012 Apr 6.

31.

(68)Ga-Labeling of RGD peptides and biodistribution.

Blom E, Velikyan I, Estrada S, Hall H, Muhammad T, Ding C, Nair M, Långström B.

Int J Clin Exp Med. 2012;5(2):165-72. Epub 2012 Apr 6.

32.

Age, sex and NK1 receptors in the human brain -- a positron emission tomography study with [¹¹C]GR205171.

Engman J, Åhs F, Furmark T, Linnman C, Pissiota A, Appel L, Frans Ö, Långström B, Fredrikson M.

Eur Neuropsychopharmacol. 2012 Aug;22(8):562-8. doi: 10.1016/j.euroneuro.2011.12.005. Epub 2012 Jan 4.

PMID:
22225860
33.

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A.

J Nucl Med. 2012 Jan;53(1):37-46. doi: 10.2967/jnumed.110.087031.

34.

Preclinical evaluation of a 68Ga-labeled biotin analogue for applications in islet transplantation.

Eriksson O, Carlsson F, Blom E, Sundin A, Långström B, Korsgren O, Velikyan I.

Nucl Med Biol. 2012 Apr;39(3):415-21. doi: 10.1016/j.nucmedbio.2011.09.009. Epub 2011 Dec 1.

PMID:
22136888
35.

The use of PIB-PET as a dual pathological and functional biomarker in AD.

Forsberg A, Engler H, Blomquist G, Långström B, Nordberg A.

Biochim Biophys Acta. 2012 Mar;1822(3):380-5. doi: 10.1016/j.bbadis.2011.11.006. Epub 2011 Nov 13.

36.

Induced terpene accumulation in Norway spruce inhibits bark beetle colonization in a dose-dependent manner.

Zhao T, Krokene P, Hu J, Christiansen E, Björklund N, Långström B, Solheim H, Borg-Karlson AK.

PLoS One. 2011;6(10):e26649. doi: 10.1371/journal.pone.0026649. Epub 2011 Oct 19.

37.

Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?

Moghbel MC, Saboury B, Basu S, Metzler SD, Torigian DA, Långström B, Alavi A.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):202-8. doi: 10.1007/s00259-011-1960-4. No abstract available.

PMID:
22009379
38.

In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study.

Santillo AF, Gambini JP, Lannfelt L, Långström B, Ulla-Marja L, Kilander L, Engler H.

Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2202-8. doi: 10.1007/s00259-011-1895-9. Epub 2011 Aug 19.

PMID:
21853308
39.

Elevated [11C]-D-deprenyl uptake in chronic Whiplash Associated Disorder suggests persistent musculoskeletal inflammation.

Linnman C, Appel L, Fredrikson M, Gordh T, Söderlund A, Långström B, Engler H.

PLoS One. 2011 Apr 19;6(4):e19182. doi: 10.1371/journal.pone.0019182.

40.

18F-ML-10, a PET tracer for apoptosis: first human study.

Höglund J, Shirvan A, Antoni G, Gustavsson SÅ, Långström B, Ringheim A, Sörensen J, Ben-Ami M, Ziv I.

J Nucl Med. 2011 May;52(5):720-5. doi: 10.2967/jnumed.110.081786. Epub 2011 Apr 15. Erratum in: J Nucl Med. 2011 Nov;52(11):1818.

41.

Increase in hypothalamic aromatase in macaque monkeys treated with anabolic-androgenic steroids: PET study with [11C]vorozole.

Takahashi K, Onoe K, Doi H, Nagata H, Yamagishi G, Hosoya T, Tamura Y, Wada Y, Yamanaka H, Yokoyama C, Mizuma H, Takashima T, Bergström M, Onoe H, Långström B, Watanabe Y.

Neuroreport. 2011 May 11;22(7):326-30. doi: 10.1097/WNR.0b013e3283460282.

PMID:
21460751
42.

Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion.

Eriksson O, Långström B, Josephsson R.

Ups J Med Sci. 2011 May;116(2):100-6. doi: 10.3109/03009734.2011.563878. Epub 2011 Mar 28.

43.

Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.

Schöll M, Almkvist O, Bogdanovic N, Wall A, Långström B, Viitanen M, Nordberg A.

J Alzheimers Dis. 2011;24(3):495-506. doi: 10.3233/JAD-2011-101563.

PMID:
21297272
44.

Ventilation distribution studies comparing Technegas and "Gallgas" using 68GaCl3 as the label.

Borges JB, Velikyan I, Långström B, Sörensen J, Ulin J, Maripuu E, Sandström M, Widström C, Hedenstierna G.

J Nucl Med. 2011 Feb;52(2):206-9. doi: 10.2967/jnumed.110.083881. Epub 2011 Jan 13.

45.

Occupancy of human brain GABA(A) receptors by the novel α5 subtype-selective benzodiazepine site inverse agonist α5IA as measured using [¹¹C]flumazenil PET imaging.

Eng W, Atack JR, Bergstrom M, Sanabria S, Appel L, Dawson GR, Sciberras D, Hargreaves RJ, Langstrom B, Burns HD.

Neuropharmacology. 2010 Dec;59(7-8):635-9. doi: 10.1016/j.neuropharm.2010.07.024. Epub 2010 Aug 7.

PMID:
20696179
46.

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.

Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Långström B, Nordberg A.

Neurobiol Aging. 2012 Jan;33(1):198.e1-14. doi: 10.1016/j.neurobiolaging.2010.06.015. Epub 2010 Aug 4.

PMID:
20688420
47.

The influence of Ceratocystis polonica inoculation and methyl jasmonate application on terpene chemistry of Norway spruce, Picea abies.

Zhao T, Krokene P, Björklund N, Långström B, Solheim H, Christiansen E, Borg-Karlson AK.

Phytochemistry. 2010 Aug;71(11-12):1332-41. doi: 10.1016/j.phytochem.2010.05.017. Epub 2010 Jun 16.

PMID:
20557909
48.

Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.

Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Långström B, Nordberg A.

Neurobiol Aging. 2011 Dec;32(12):2320.e15-32. doi: 10.1016/j.neurobiolaging.2010.04.028. Epub 2010 Jun 9.

PMID:
20538374
49.

In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours--impact of peptide mass.

Velikyan I, Sundin A, Eriksson B, Lundqvist H, Sörensen J, Bergström M, Långström B.

Nucl Med Biol. 2010 Apr;37(3):265-75. doi: 10.1016/j.nucmedbio.2009.11.008. Epub 2010 Jan 15.

PMID:
20346866
50.

High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters.

Forsberg A, Almkvist O, Engler H, Wall A, Långström B, Nordberg A.

Curr Alzheimer Res. 2010 Feb;7(1):56-66.

PMID:
20205671

Supplemental Content

Loading ...
Support Center